# Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy

> **NCT05662410** · PHASE4 · COMPLETED · sponsor: **Kim's Eye Hospital** · enrollment: 30 (actual)

## Conditions studied

- Pachychoroid Neovasculopathy

## Interventions

- **DRUG:** Three monthly injections of intravitreal aflibercept

## Key facts

- **NCT ID:** NCT05662410
- **Lead sponsor:** Kim's Eye Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-26
- **Primary completion:** 2024-05-24
- **Final completion:** 2024-05-26
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-05-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05662410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05662410, "Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05662410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*